| Previous Close | 1.1800 |
| Open | 0.0000 |
| Bid | 1.0900 x 0 |
| Ask | 1.1000 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 659,023 |
| Market Cap | 66.721M |
| Beta (5Y Monthly) | -2.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0550 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sona Nanotech Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sona Nanotech Inc.
- Newsfile
Sona Nanotech Provides Corporate Update
Halifax, Nova Scotia--(Newsfile Corp. - November 30, 2020) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company"), a developer of rapid, point-of-care diagnostic tests, received further feedback from Health Canada, subsequent to its withdrawal of its application for an Interim Order authorization ("IO") for the marketing of its rapid, COVID-19 antigen test. As part of its review, Health Canada commissioned an evaluation from the National Microbiology Laboratory (NML) whose evaluation produced discordant ...
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sona Nanotech Inc. (SNANF) Investigation
NEW YORK, NY / ACCESSWIRE / November 27, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sona Nanotech Inc.
